Publicaciones en las que colabora con Alvaro Mena de Cea (5)
2023
-
Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort
European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 221-226
2022
-
Discontinuation due to neuropsychiatric adverse events with efavirenz-and dolutegravir-based antiretroviral therapy: a comparative real-life study
European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 207-211
2019
-
Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines
Journal of the International Association of Providers of AIDS Care, Vol. 18
-
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
Basic and Clinical Pharmacology and Toxicology, Vol. 124, Núm. 4, pp. 479-490
2017
-
Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: Potential role as a biomarker of HIV replication
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 11, pp. 3159-3162